Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Other financing activities (2020 - 2026)

C4 Therapeutics has reported Other financing activities over the past 7 years, most recently at $56000.0 for Q1 2026.

  • For Q1 2026, Other financing activities fell 48.62% year-over-year to $56000.0; the TTM value through Mar 2026 reached $221000.0, down 45.7%, while the annual FY2025 figure was $274000.0, 28.27% down from the prior year.
  • Other financing activities for Q1 2026 was $56000.0 at C4 Therapeutics, up from $1000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $297000.0 in Q3 2024 and troughed at -$1000.0 in Q4 2023.
  • A 5-year average of $111538.5 and a median of $104000.0 in 2023 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: soared 7433.33% in 2022 and later plummeted 52.73% in 2023.
  • Year by year, Other financing activities stood at $150000.0 in 2022, then crashed by 100.67% to -$1000.0 in 2023, then surged by 200.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then soared by 5500.0% to $56000.0 in 2026.
  • Business Quant data shows Other financing activities for CCCC at $56000.0 in Q1 2026, $1000.0 in Q4 2025, and $164000.0 in Q3 2025.